Market Cap
₹3,67,290 Cr.
P/E
41.24
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
15.13%
3yr Average
9.4%
5yr Average
8.59%
Net Profit Margin
Latest
19.31%
3yr Average
12.15%
5yr Average
11.42%
ROCE
Latest
16.91%
3yr Average
16.82%
5yr Average
14.84%
Debt to Equity
Latest
0.11
3yr Average
0.07
5yr Average
0.13
Market Share
6.42% (as of Jul 22)
Anti - Diabetes - Market Share
0.13% (as of Jul 22)
Anti-Infectives - Market Share
0.01% (as of Feb 20)
Anti-Malarial - Market Share
2.43% (as of Nov 21)
Antineo Plastic - Market Share
3.41% (as of Nov 21)
Blood Related - Market Share
6.88% (as of Jul 22)
Cardiovascular - Market Share
0.19% (as of Nov 21)
Dermatology - Market Share
6.24% (as of Nov 21)
Endocrinology - Market Share
7.45% (as of Jul 22)
Gastro-Intestinal - Market Share
5.97% (as of Nov 21)
Gynecology - Market Share
22.70% (as of Nov 21)
Neurological - Market Share
13.47% (as of Nov 21)
Ophthalmology - Market Share
2.98% (as of Nov 21)
Pain - Market Share
7.70% (as of Dec 22)
Pharmaceutical Sector - Market Share
3.63% (as of Nov 21)
Respiratory - Market Share
0.75% (as of Jul 22)
Sex Stimulants - Market Share
3.62% (as of Nov 21)
Urology - Market Share
1.91% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • US DMF Filings (.)
    • US DMF Approval (.)
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Garlic Pearls
    Revital
    Volini
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis